ライフサイエンスコーパス: n-

1 IOP following washout for patients using 0 (n = 100), 1 (n = 705), 2 (n = 355), 3 (n = 214), or 4 (n

2 (11 424/16 346 [69.9%]) and, overall, 67.0% (n = 11 033) had an underlying comorbidity.

3 g washout for patients using 0 (n = 100), 1 (n = 705), 2 (n = 355), 3 (n = 214), or 4 (n = 26) medica

4 Cohort 1 (n = 24,475) was examined during 1971 to 1991 and followe

5 Higher E-selectin (n = 1,810) and ICAM-1 (n = 1,548) at Y7 were associated with black race, smokin

6 PCV13 serotypes were responsible for 20.1% (n = 4033), while serotype 8 (3881/20 108 [19.3%]), 12F (

7 Zr-DFO-azepin-onartuzumab to 56.9% +/- 4.1% (n = 3), with isolated RCYs of 41.2% +/- 10.6% (n = 3) an

8 n = 420), decrease in visual acuity (32.1%; n = 317), generalized eye pain (7.4%; n = 73), visual fi

9 ticipants were split at 80% (n = 3494), 10% (n = 437), and 10% (n = 437) by using split-sample valida

10 t at 80% (n = 3494), 10% (n = 437), and 10% (n = 437) by using split-sample validation into training,

11 (83%, n = 25), followed by genotype 4 (10%, n = 3) and genotype 3 (7%, n = 2).

12 active control at 6-month follow-up (k = 10; n = 738; SMD = -0.45, 95% CI -0.82 to -0.08).

13 t year postpartum, 64% (n = 19,344) and 13% (n = 3,994) did not migrate and resided within and outsid

14 urgery was performed within 24 hours in 18% (n = 180), within 48 hours in 20.6% (n = 203), within 72

15 nts with chronic liver disease and COVID-19 (n = 375), incidence of acute liver injury was lower in L

16 patients using 0 (n = 100), 1 (n = 705), 2 (n = 355), 3 (n = 214), or 4 (n = 26) medications was 0.2

17 For children alive in 2015 (n = 13,729,000), this would avert 240,000 (95% UI 65,000

18 between December 11, 2017, and May 4, 2018 (n = 79) from 29 U.S. sites.

19 ng 0 (n = 100), 1 (n = 705), 2 (n = 355), 3 (n = 214), or 4 (n = 26) medications was 0.2 (2.8), 5.7 (

20 Mortality rate was 22.3% (n = 25); 72.3% (n = 81) were hospitalized and 26.8% (n =

21 tive in 42% (n = 231) and negative in 57.3% (n = 311).

22 Mortality rate was 22.3% (n = 25); 72.3% (n = 81) were hospitalized and 26.8% (n = 30) admitted to

23 majority underwent excisional biopsy (55.3%, n = 302/546) or lumpectomy (wide excision) (38.5%, n = 2

24 4%; n = 73), visual field disturbance (4.3%; n = 42), and postoperative ocular pain (3.4%; n = 34).

25 1 (n = 705), 2 (n = 355), 3 (n = 214), or 4 (n = 26) medications was 0.2 (2.8), 5.7 (3.3), 6.9 (3.7),

26 = 42), and postoperative ocular pain (3.4%; n = 34).

27 32.1%; n = 317), generalized eye pain (7.4%; n = 73), visual field disturbance (4.3%; n = 42), and po

28 Surgical margins were positive in 42% (n = 231) and negative in 57.3% (n = 311).

29 symptoms more than inactive control (k = 46; n = 3,389; standardised mean difference [SMD] = -0.82, 9

30 2/546) or lumpectomy (wide excision) (38.5%, n = 210/546).

31 g symptoms were flashes and floaters (42.5%; n = 420), decrease in visual acuity (32.1%; n = 317), ge

32 nt in domestic cat versus domestic dog (51%, n = 32 of 62 cats; 15%, 11 of 70 dogs were positive for

33 = 3), with isolated RCYs of 41.2% +/- 10.6% (n = 3) and radiochemical purity of more than 90%.

34 in 18% (n = 180), within 48 hours in 20.6% (n = 203), within 72 hours in 21.7% (n = 214), and within

35 .7% (n = 214), and within 96 hours in 22.6% (n = 223) of the appointment.

36 (n = 571) intended to be vaccinated, 31.6% (n = 313) were not sure, and 10.8% (n = 107) did not inte

37 The incidence of LARS was 82.6% (n = 109/132), which was minor in 26/132 (19.7%) and majo

38 The triads, BTMPA-Im->AlPorF(n)-Ph-C(60) (n = 0, 3, 5), were constructed by linking the fullerene

39 regnancy and the first year postpartum, 64% (n = 19,344) and 13% (n = 3,994) did not migrate and resi

40 LD-Na resulted in reclassification of 16.7% (n = 672) of patients on the WL.

41 n 20.6% (n = 203), within 72 hours in 21.7% (n = 214), and within 96 hours in 22.6% (n = 223) of the

42 genotype 4 (10%, n = 3) and genotype 3 (7%, n = 2).

43 d, 31.6% (n = 313) were not sure, and 10.8% (n = 107) did not intend to be vaccinated.

44 72.3% (n = 81) were hospitalized and 26.8% (n = 30) admitted to the intensive care unit (ICU).

45 The participants were split at 80% (n = 3494), 10% (n = 437), and 10% (n = 437) by using spl

46 The majority had HCV genotype 1 (83%, n = 25), followed by genotype 4 (10%, n = 3) and genotyp

47 CI] -1.02 to -0.63) and active control (k-9; n = 662; SMD = -0.35, 95% CI -0.56 to -0.14) at posttrea

48 TX plus nelarabine, had a 5-year DFS of 91% (n = 147).

49 ng of asymptomatic laboratory abnormalities (n = 4), hepatitis and colitis (n = 2).

50 and TBI patients (categories 2 and 3 above, n = 59/148).

51 dy with a total of 857 subjects from the AD (n = 213), MCI (n = 322), and control (CN, n = 322) group

52 ng), including a subset of patients with AF (n = 28) with low CHA(2)DS(2)-VASc score (0/1 for men/wom

53 st prices of noninsulin antidiabetic agents (n = 10) increased by 165%, and net prices decreased by 1

54 CI: 3.1 to 13.6) for TLNB followed by ALND (n = 203) and 4.3% (2 of 46, 95% CI: 0.5 to 14.8) for TAD

55 % CI: 0.5 to 14.8) for TAD followed by ALND (n = 77).

56 ol (n = 720) or the standard protocol alone (n = 773).

57 r metastases assigned to (177)Lu-PSMA alone (n = 31) or in combination with SIRT (n = 5) were retrosp

58 umors harbored FGFR1 or FGFR2 amplification (n = 20), FGFR2 or FGFR3 single-nucleotide variants (n =

59 of depression cases, 2 of which (n = 38 and n = 100; 67% collectively) were associated with increase

60 rotein-treated controls (1012 vg per animal, n = 10 per group) with PHP.B vectors.

61 e homing was blocked by integrin antibodies (n = 5).

62 double-blind RCT and randomized into 4 arms (n = 23): HP-diet and beta-cryptoxanthin (hypocaloric HP-

63 nd combined chylothorax and chylous ascites (n = 4; 16%).

64 ignificantly associated with incident ASCVD (n = 1386 events; median follow-up, 25.2 years; hazard ra

65 imized parameters, to each polymorphic AT1R (n = 6).

66 t 1.0), or NEVKP before autotransplantation (n = 5 per group).

67 esection and intestinal autotransplantation (n = 12), ex vivo Whipple procedure and liver autotranspl

68 ple procedure and liver autotransplantation (n = 8) and multivisceral ex vivo procedure (n = 7).

69 tobiprole (n = 335) or vancomycin/aztreonam (n = 344).

70 selected on a first-come first-served basis (n = 130; M age = 45.8, SD = 8; M BMI = 34.48 kg/m2, SD =

71 ly injections of either 1.25 mg bevacizumab (n = 86) or 0.5 mg ranibizumab (n = 84).

72 Despite blacks (n = 407) reporting higher levels of medical mistrust (40

73 there was simultaneous genetic loss of both (n = 87) (mean survival 1670.8 +/- 183.5 days vs 885.1 +/

74 d unusual yellow discoloration of the bowel (n = 3) and bowel infarction (n = 2).

75 erformed metabolite profiling in both brain (n = 109) and matching serum samples (n = 566) to identif

76 In 3 collections of human postmortem brain (n = 206) and 1 collection of blood samples (N = 1132) of

77 matched patients with svPPA (n = 70), bvFTD (n = 70) and Alzheimer's disease (n = 70).

78 son sera from PCR-confirmed influenza cases (n = 50), and (ii) an immunology cohort, consisting of pa

79 sociation analysis of MD (n = 135,458 cases, n = 344,901 controls) and gene expression levels from 21

80 at presentation with ICI myocarditis (cases, n = 101) to that from patients receiving an ICI who did

81 th 25.0-37.5% of deaths from medical causes (n = 8).

82 79 patients were randomized to ceftobiprole (n = 335) or vancomycin/aztreonam (n = 344).

83 Indications were chylothorax (n = 19; 76%), cervical lymphatic fistula (n = 2; 8%), an

84 ents; HR, 0.91 [95% CI, 0.76-1.09]), or CKD (n = 2433 events; HR, 0.98 [95% CI, 0.65-1.11]).

85 D (n = 213), MCI (n = 322), and control (CN, n = 322) groups, we used structural MRI data and neurops

86 With a training cohort (n = 40) and a blinded validation cohort (n = 90) acquire

87 rt (n = 40) and a blinded validation cohort (n = 90) acquired from CDC, the Lyme Immunochip identifie

88 bnormalities (n = 4), hepatitis and colitis (n = 2).

89 local (n= 6), distant (n = 3), and combined (n = 3)-at a median of 9.8 months from diagnosis (range,

90 to difficulties in integrating complementary n- and p-channel transistors in a common quantum dot act

91 olated from hindlimb muscle of control (CON, n = 11-12) and IUGR (n = 12) late gestation fetal sheep.

92 32) that trained to benchmarks and control (n = 32) that trained using locally available robotic ski

93 andomized into exercise (n = 23) or control (n = 22) groups.

94 ervention], n = 282) or usual care (control, n = 287), in which no medication changes were mandated.

95 ne before the intervention in 2014 (control: n = 1,301, intervention: n = 1,357), the other 2 years a

96 e other 2 years afterwards in 2016 (control: n = 996, intervention: n = 1,035).

97 Disorder (MDD) (n = 64) to healthy controls (n = 64) using a comprehensive battery of nine value-base

98 28-60 years), healthy individuals (controls, n = 24), mice, and rats.

99 Surgical correlation (n = 4) revealed unusual yellow discoloration of the bowe

100 ry in HIV-infected adults with cryptococcal (n = 31) and noncryptococcal (n = 12) meningitis and in h

101 s examined with patient sera (n = 31), CSFs (n = 11), longitudinal serum samples (n = 15), and using

102 e 960 mg of oral co-trimoxazole twice daily (n = 170) or matched placebo (n = 172) for between 12 and

103 lysis of publicly available microarray data (n = 303 profiles) measured in livers of fathead minnows

104 ap by fitting a computational model to data (n = 1754) from a modified serial dictator game, to explo

105 with infusion of terlipressin (2-12 mg/day; n = 60) or noradrenaline (0.5-3.0 mg/h; n = 60).

106 ese risk factors on odds of type 2 diabetes (n = 5,042 cases) and HbA(1c) levels (n = 175,156).

107 nd individuals with prediabetes or diabetes (n = 8/group).

108 We created discovery (n = 2405) and validation (n = 2313) cohorts using data f

109 70), bvFTD (n = 70) and Alzheimer's disease (n = 70).

110 collected from healthy (n = 5) and diseased (n = 5) sites of each patient.

111 s experienced relapse-local (n= 6), distant (n = 3), and combined (n = 3)-at a median of 9.8 months f

112 andomly assigned to 4 training groups: Dome (n = 29), dV-Trainer (n = 30), and DVSS (n = 32) that tra

113 Diabetic eyes without DR (n = 138) and eyes with mild/moderate nonproliferative DR

114 common therapeutic needs involved new drugs (n = 149, 51.0%), cell regeneration (n = 115, 39.4%), and

115 ome (n = 29), dV-Trainer (n = 30), and DVSS (n = 32) that trained to benchmarks and control (n = 32)

116 ceived anti-VEGF therapy according to a T&E (n = 163) or PRN (n = 101) regimen.

117 m 118 children randomly assigned to PCIT-ED (n = 60) or waitlist (n = 58) at baseline and late positi

118 y) (n = 20); AgP+CS/EMD (n = 20); CP+CS/EMD (n = 20).

119 (conservative surgery) (n = 20); AgP+CS/EMD (n = 20); CP+CS/EMD (n = 20).

120 students diagnosed to have refractive error (n = 92), myopia constituted 83/92 (90.2%) of the student

121 Twenty-one patients (escalation, n = 12; expansion, n = 9) with advanced chondrosarcoma r

122 ls in the United States (n = 13) and Europe (n = 3).

123 omen (n = 45) were randomized into exercise (n = 23) or control (n = 22) groups.

124 one patients (escalation, n = 12; expansion, n = 9) with advanced chondrosarcoma received ivosidenib

125 umor biopsies positive for PD-L1 expression (n = 28/40 evaluable), and response rates were higher in

126 eline vision (n = 2), stable mild exudation (n = 1), and progressive vasoproliferation with traction

127 ily netarsudil 0.02%/latanoprost 0.005% FDC (n = 238), netarsudil 0.02% only (n = 243), or latanopros

128 method to detect patients with fibromyalgia (n = 252, 126 controls and 126 patients with fibromyalgia

129 x (n = 19; 76%), cervical lymphatic fistula (n = 2; 8%), and combined chylothorax and chylous ascites

130 For n = 18 inpatients (78.26%) hospitalised for at least 7 d

131 ariants (n = 19), or FGFR1 or FGFR3 fusions (n = 9).

132 TIE, only 3.6 mL of residues was generated (n = 12) over 60-240 mL in reference methods (n = 3).

133 confined to the dorsal portion of the gland (n = 161), also demonstrated UDD to be a significant pred

134 = 26) and 225 nontransplant recipients (GNB n = 114; SAB n = 111) were included for clinical analysi

135 Fifty-five transplant recipients (GNB n = 29; SAB n = 26) and 225 nontransplant recipients (GN

136 In the public setting, the non-JADE group (n = 3,587) underwent structured evaluation for risk fact

137 In the control (sham) group (n = 27), palatal wounds, after free gingival grafts (FGG

138 BV patients were randomized to four groups (n = 17/group) after seven-day oral metronidazole treatme

139 consenting patients (50 Gy, n = 937; 40 Gy, n = 917) were enrolled from 2009-2014 from eight centers

140 A total of 1,854 consenting patients (50 Gy, n = 937; 40 Gy, n = 917) were enrolled from 2009-2014 fr

141 day; n = 60) or noradrenaline (0.5-3.0 mg/h; n = 60).

142 ng Questionnaire for Disaster Mental Health (n = 828).

143 nt, GCF samples were collected from healthy (n = 5) and diseased (n = 5) sites of each patient.

144 performed procedure was ex vivo hepatectomy (n = 18), followed by ex vivo resection and intestinal au

145 d ratio [HR], 1.06 [95% CI, 0.89-1.26]), HF (n = 1396 events; HR, 0.91 [95% CI, 0.76-1.09]), or CKD (

146 gs identified as recently infected with HIV (n = 23) were analyzed for clustering of their viral sequ

147 onal study evaluated 6 individuals with HIV (n = 4 with viral suppression using antiretroviral [ART]

148 ts] and 1.02 [95% CI, 0.92-1.14] in CLUE II [n = 1497 events]).

149 ven groups, from diffusion-weighted imaging (n = 300), we compared white matter fractional anisotropy

150 fusivity (MD), and from T1-weighted imaging (n = 333), subcortical volumes and cortical thickness in

151 n of the bowel (n = 3) and bowel infarction (n = 2).

152 IV-uninfected (n = 314) versus HIV-infected (n = 42).

153 thy control subjects with neither infection (n = 10).

154 llected after PCR-confirmation of infection (n = 94).

155 requent pathophysiologies were inflammation (n = 104, 35.6%) related to sepsis, respiratory failure,

156 organ dysfunction; and direct tissue injury (n = 64, 21.9%) including brain and spinal cord trauma.

157 eriod of the limit cycles becomes an integer n > 1 multiple of the driving period.

158 n in 2014 (control: n = 1,301, intervention: n = 1,357), the other 2 years afterwards in 2016 (contro

159 rds in 2016 (control: n = 996, intervention: n = 1,035).

160 reduction (removal of 1 drug [intervention], n = 282) or usual care (control, n = 287), in which no m

161 Studies of patient-provider interventions (n = 12), health information technologies (n = 11), and h

162 s (n = 11), and health system interventions (n = 88) indicated higher cancer screening rates with pat

163 th those who needed endotracheal intubation (n = 12) (median [interquartile range], 11 [8-15] cm H(2)

164 tients were included in the group with ITBA (n = 10 of 35; 28.6%), and 25 patients were included in t

165 muscle of control (CON, n = 11-12) and IUGR (n = 12) late gestation fetal sheep.

166 tors and complications only, while the JADE (n = 9,601) group received a JADE report with group empow

167 s commonly clinical or biochemical jaundice, n = 30 (28%) each.

168 F1A occurred without genetic loss of L2HGDH (n = 5), the survival was significantly greater than wher

169 ed-based functional connectivity in a large (n = 1000) normative connectome.

170 abetes (n = 5,042 cases) and HbA(1c) levels (n = 175,156).

171 rapy (n = 36) versus treatment waiting list (n = 30).

172 4 sunscreen products, formulated as lotion (n = 12), aerosol spray (n = 12), nonaerosol spray (n = 1

173 inal serum samples (n = 15), and using mAbs (n = 14) generated from peripheral B cells of two patient

174 of 857 subjects from the AD (n = 213), MCI (n = 322), and control (CN, n = 322) groups, we used stru

175 gest genome-wide association analysis of MD (n = 135,458 cases, n = 344,901 controls) and gene expres

176 gnosed with Major Depressive Disorder (MDD) (n = 64) to healthy controls (n = 64) using a comprehensi

177 = 17 out of 29, 59%) and distant metastases (n = 20 out of 70, 29%), but less frequent in treated dis

178 less frequent in treated distant metastases (n = 9 out of 94, 10%).

179 s common in untreated lymph node metastases (n = 17 out of 29, 59%) and distant metastases (n = 20 ou

180 n = 12) over 60-240 mL in reference methods (n = 3).

181 Ten weeks old male C57BL/6 mice (n = 9) underwent left anterior descending (LAD) coronary

182 C57BL/6J female mice (n = 18) were first treated with antibiotics for 4 weeks

183 detection limit was calculated as 22 ng/mL (n = 6) using the 3 Sb/m formula.

184 onth 24, the mean IOP was 12.6 +/- 4.4 mmHg (n = 29, P = 0.519) on 2.0 +/- 1.6 (P = 0.457) glaucoma m

185 4%), and immune and inflammatory modulation (n = 79, 27.1%).

186 f nicotine replacement therapy at 12 months (n = 257; 8.1% vs 8.2%).

187 ttransplant variables until 3 and 12 months (n = 65), the obtained models showed good performance to

188 polarization (half-widths: 0.25 +/- 0.08 ms, n = 19 wild-type, 0.60 +/- 0.17 ms, n = 21 Kv3.3KO, p =

189 0.08 ms, n = 19 wild-type, 0.60 +/- 0.17 ms, n = 21 Kv3.3KO, p = 0.0001).

190 Z heterozygotes confirmed by sequencing (MZ; n = 74) had lower post-bronchodilator FEV(1) (P = 0.007)

191 e 1,089 CHB patients, classified as no-NASH (n = 904, 83%) or NASH (n = 185, 17%), with 52 (6%) versu

192 lassified as no-NASH (n = 904, 83%) or NASH (n = 185, 17%), with 52 (6%) versus 27 (15%) experiencing

193 d to nelarabine (n = 323) and no nelarabine (n = 336) were 88.2% +/- 2.4% and 82.1% +/- 2.7%, respect

194 with T-ALL randomly assigned to nelarabine (n = 323) and no nelarabine (n = 336) were 88.2% +/- 2.4%

195 were 1.17 [95% CI, 0.87-1.56] in the NHANES [n = 1012 events] and 1.02 [95% CI, 0.92-1.14] in CLUE II

196 h cryptococcal (n = 31) and noncryptococcal (n = 12) meningitis and in heathy control subjects with n

197 Chronic conditions were often noted (n = 156, 53.4%) as contributing to adverse outcomes.

198 oliferative DR (NPDR; n = 125), severe NPDR (n = 20), and proliferative DR (PDR; n = 72) were include

199 ith mild/moderate nonproliferative DR (NPDR; n = 125), severe NPDR (n = 20), and proliferative DR (PD

200 ient of K(d) ~16 muM and Hill coefficient of n ~2.

201 ied neuroimaging in a longitudinal sample of n = 146 participants aged 12-30.

202 not, leading to the creation of a W state of n + m - 2 electrons in the successful case.

203 Overall safety was comparable between OH+ (n = 288, 27.5%) and OH- (n = 730, 69.7%), except for hig

204 arable between OH+ (n = 288, 27.5%) and OH- (n = 730, 69.7%), except for higher frequency of syncope

205 only (n = 243), or latanoprost 0.005% only (n = 237).

206 0.005% FDC (n = 238), netarsudil 0.02% only (n = 243), or latanoprost 0.005% only (n = 237).

207 e PreCARE cohort of pregnant women in Paris (n = 9,579).

208 th survey taken by a subset of participants (n = 157,366) in the UK Biobank.

209 Overall, 57.6% of participants (n = 571) intended to be vaccinated, 31.6% (n = 313) were

210 In PESA participants (n = 4,184 subjects free of cardiovascular disease), PA w

211 When 25% participated (n = 101), there was a 9.1% relative reduction in inciden

212 amage compared to matched glaucoma patients (n = 26) without senolytic exposure.

213 edictive tool for graft failure in patients (n = 181) who received a kidney transplant in Olmsted Cou

214 fected cells, whereas PV from IRI- patients (n = 32) primarily increased hTLR7 and hNOD2 activation.

215 in (an inflammatory marker) in MWA patients (n = 11) who experienced headaches and visual aura in the

216 A subset of patients (n = 116) enrolled in 3 phase-3 randomized clinical trial

217 Thirteen percent of patients (n = 5) had treatment-related grade 3 or 4 adverse events

218 A subset of patients (n = 98) were selected for a WES-only pipeline if the his

219 otopic liver transplantation (OLT) patients (n = 35) decreased activation of hTLR4- and hTLR9-transfe

220 re NPDR (n = 20), and proliferative DR (PDR; n = 72) were included.

221 A comparison (pre-PDT [n = 220 cases] vs. PDT [n = 238 cases]) revealed PDT era

222 comparison (pre-PDT [n = 220 cases] vs. PDT [n = 238 cases]) revealed PDT era patients were of older

223 iferation with traction leading to phthisis (n = 2).

224 le twice daily (n = 170) or matched placebo (n = 172) for between 12 and 42 months.

225 s 28 days apart (20 ug, n = 201) or placebo (n = 199) and were followed up for 72 weeks.

226 150 mg/d of resveratrol (n = 20) or placebo (n = 21) for 6 mo.

227 therapy according to a T&E (n = 163) or PRN (n = 101) regimen.

228 (n = 8) and multivisceral ex vivo procedure (n = 7).

229 blue visual HPTs plus the standard protocol (n = 720) or the standard protocol alone (n = 773).

230 nel of 24 members, including pulmonologists (n = 17), thoracic radiologists (n = 5), and thoracic sur

231 ative vitreoretinopathy (PVR) (n = 30), PVR (n = 16) and proliferative diabetic retinopathy (PDR) wit

232 thout proliferative vitreoretinopathy (PVR) (n = 30), PVR (n = 16) and proliferative diabetic retinop

233 monologists (n = 17), thoracic radiologists (n = 5), and thoracic surgeons (n = 2), was formed.

234 bevacizumab (n = 86) or 0.5 mg ranibizumab (n = 84).

235 First impression ratings (n = 227) of Barbary macaques' social and health traits w

236 abetic retinopathy (PDR) with tractional RD (n = 8).

237 w drugs (n = 149, 51.0%), cell regeneration (n = 115, 39.4%), and immune and inflammatory modulation

238 hin canine mammary tumor associated regions (n = 471).

239 prescribing in all analyses; the remainder (n = 6) had a mix of positive and null findings.

240 d to receive either 150 mg/d of resveratrol (n = 20) or placebo (n = 21) for 6 mo.

241 Rhesus macaques (RMs) (n = 13) were infected with simian/human immunodeficiency

242 Intra- and inter-day RSD% (n = 3) at two concentration levels of 25 and 250 ug L(-1

243 5 nontransplant recipients (GNB n = 114; SAB n = 111) were included for clinical analysis.

244 -five transplant recipients (GNB n = 29; SAB n = 26) and 225 nontransplant recipients (GNB n = 114; S

245 , CSFs (n = 11), longitudinal serum samples (n = 15), and using mAbs (n = 14) generated from peripher

246 brain (n = 109) and matching serum samples (n = 566) to identify differentially expressed metabolite

247 Higher E-selectin (n = 1,810) and ICAM-1 (n = 1,548) at Y7 were associated

248 dditionally, patients exposed to senolytics (n = 9) did not exhibit faster progression of glaucomatou

249 recognition was examined with patient sera (n = 31), CSFs (n = 11), longitudinal serum samples (n =

250 o a training (n = 318) and a validation set (n = 189).

251 cal and isotopic analysis of ceramic sherds (n = 125) from Pastoral Neolithic archaeological contexts

252 alone (n = 31) or in combination with SIRT (n = 5) were retrospectively analyzed.

253 ith 0.04-mm thickness and 0.15-mm pore size; n = 7).

254 ormulated as lotion (n = 12), aerosol spray (n = 12), nonaerosol spray (n = 12), and pump spray (n =

255 ), aerosol spray (n = 12), nonaerosol spray (n = 12), and pump spray (n = 12).

256 , nonaerosol spray (n = 12), and pump spray (n = 12).

257 16 teaching hospitals in the United States (n = 13) and Europe (n = 3).

258 ted genes were either from human BC studies (n = 294) or from within canine mammary tumor associated

259 Twenty-five studies (n = 15 785) evaluated the accuracy of screening tests; a

260 Most studies (n = 30) identified a positive association between paymen

261 e original methods in a multinational study (n = 4,098 participants, 19 countries, 13 languages), adj

262 In COPD (SPIROMICS) bronchoscopy sub-study (n = 195).

263 global visual processing in human subjects (n = 10) was correlated with the fMRI response evoked by

264 d not develop myocarditis (control subjects, n = 92).

265 radiologists (n = 5), and thoracic surgeons (n = 2), was formed.

266 ients who underwent tricuspid valve surgery (n = 344), a post-operative improvement in MELD-XI score

267 three groups: AgP+CS (conservative surgery) (n = 20); AgP+CS/EMD (n = 20); CP+CS/EMD (n = 20).

268 th age- and sex-matched patients with svPPA (n = 70), bvFTD (n = 70) and Alzheimer's disease (n = 70)

269 s (n = 12), health information technologies (n = 11), and health system interventions (n = 88) indica

270 were split into training (n = 97) and test (n = 49) cohorts.

271 ative for SARS-CoV-2 in all patients tested (n = 39).

272 HLHS/TGA (n = 24), CHD-other (50), and CHD-related (34) groups eac

273 hereas Ni(4+) and Fe(3+) are observed in the n = 5 superlattice.

274 Holding m = 1, spectroscopy reveals that the n = 1 superlattice contains Ni(3+) and Fe(4+) , whereas

275 linical trial of prolonged exposure therapy (n = 36) versus treatment waiting list (n = 30).

276 pression using antiretroviral [ART] therapy; n = 2 with rebound viremia after stopping ART), who prov

277 training groups: Dome (n = 29), dV-Trainer (n = 30), and DVSS (n = 32) that trained to benchmarks an

278 red seven PLWH were divided into a training (n = 318) and a validation set (n = 189).

279 ember 2017 and who were split into training (n = 97) and test (n = 49) cohorts.

280 ts who successfully completed the NIV trial (n = 18) compared with those who needed endotracheal intu

281 y, a representative cohort of British twins (n = 2,232) followed across the first 2 decades of life.

282 tramuscular injections 28 days apart (20 ug, n = 201) or placebo (n = 199) and were followed up for 7

283 gnant African women who were HIV-uninfected (n = 314) versus HIV-infected (n = 42).

284 After 3 years of follow-up (n = 1,775, 9 RCTs), all-cause mortality was significantl

285 patient cohort with full clinical follow-up (n = 928), we investigated whether molecular subtypes can

286 created discovery (n = 2405) and validation (n = 2313) cohorts using data from 4 recent trials (UKALL

287 , FGFR2 or FGFR3 single-nucleotide variants (n = 19), or FGFR1 or FGFR3 fusions (n = 9).

288 roliferation with return to baseline vision (n = 2), stable mild exudation (n = 1), and progressive v

289 ly assigned to PCIT-ED (n = 60) or waitlist (n = 58) at baseline and late positive potential (LPP) da

290 sation in 2 trials of bupropion at 26 weeks (n = 523; 17% [300 mg] and 6% [150 mg] vs 10% [placebo];

291 4 subgroups of depression cases, 2 of which (n = 38 and n = 100; 67% collectively) were associated wi

292 ation (29.0% vs 15.7%, P < .01) than whites (n = 121), blacks were only slightly less likely than whi

293 On separate study days, adults with (n = 26) and without (n = 23) ADHD completed the bandit t

294 tudy days, adults with (n = 26) and without (n = 23) ADHD completed the bandit task at baseline, and

295 Obese, black South African women (n = 45) were randomized into exercise (n = 23) or contro

296 d chondrosarcoma received ivosidenib (women, n = 8; median age, 55 years; range, 30-88 years; 11 had

297 PWA) device (Atcor Medical Sphygmocor XCEL) (n = 5) revealed central aortic systolic pulse (CASP) and

298 and 10-fold lower during the follow-up year (n = 18, P = .03).

299 In addition, in younger (4-6 years, n = 67), but not older (6-8 years, n = 70) children, hab

300 -6 years, n = 67), but not older (6-8 years, n = 70) children, habitual sleep duration was related to